CHEK2 and cancer: Second, ctDNA panel (Guardant360®) utilized in this study did not cover several of the common cancer susceptibility genes, such as CHEK2, MSH2, MSH6, and PMS2. Third, the sample size was small, and over 50% of the patients had one of the top three cancer types (pancreatic, colorectal, and lung).